Close Menu

NEW YORK (GenomeWeb) – The GenomeWeb Index fell nearly 3 percent in April, posting its first loss for 2019 amid wider losses for biotech stocks.

The index underperformed the Dow Jones Industrial Average and the Nasdaq, which gained nearly 3 percent and nearly 5 percent, respectively, but outperformed the Nasdaq Biotechnology Index, which fell nearly 5 percent. Individual stock performance in the April GenomeWeb Index was mostly negative as 17 of the 30 stocks saw losses and 13 saw gains.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.